A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C

Clinical trial NCT02727751 · COMPLETED

Trial details

NCT number: NCT02727751
Sponsor: Ardelyx
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Constipation Predominant Irritable Bowel Syndrome

Start date: 2016-03-01
Primary completion: 2017-10-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.